Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Cullis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical and Laboratory Haematology|January 1, 1991
Acute epiglottitis in immunocompromised patients--a report of two casesJ O Cullis, R D Hyde
Lancet (London, England)|October 27, 1990
Jehovah's Witnesses with leukaemiaJ O Cullis, A G Smith
Blood|April 24, 1999
Patients with essential thrombocythemia do not express BCR-ABL transcriptsS Hackwell, F Ross, J O Cullis
International Journal of Laboratory Hematology|July 31, 2008
Cost-effectiveness of rituximab in refractory cold agglutinin diseaseU Panwar, C Mathews, J O Cullis
Nuclear Medicine Communications|January 1, 1993
Unresolved pulmonary embolism: the role of fibrinolysisJ O Cullis, M Chisholm, D M Ackery
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Graft vs. leukaemia reactions in chronic myeloid leukaemiaJ O Cullis, A J Barrett, J M Goldman
Vox Sanguinis|January 1, 1995
Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destructionJ O Cullis, N Win, J M Dudley, et al.
Bone Marrow Transplantation|January 1, 1991
Is graft versus leukaemia separable from graft versus host disease?Y Z Jiang, D Macdonald, J O Cullis, et al.
Leukemia|January 1, 1994
Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: studies in antigen-processing defective cell linesJ O Cullis, A J Barrett, J M Goldman, et al.
Bone Marrow Transplantation|February 1, 1993
T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemiaY Z Jiang, J O Cullis, E J Kanfer, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical and Laboratory Haematology|January 1, 1991
Acute epiglottitis in immunocompromised patients--a report of two casesJ O Cullis, R D Hyde
Lancet (London, England)|October 27, 1990
Jehovah's Witnesses with leukaemiaJ O Cullis, A G Smith
Blood|April 24, 1999
Patients with essential thrombocythemia do not express BCR-ABL transcriptsS Hackwell, F Ross, J O Cullis
International Journal of Laboratory Hematology|July 31, 2008
Cost-effectiveness of rituximab in refractory cold agglutinin diseaseU Panwar, C Mathews, J O Cullis
Nuclear Medicine Communications|January 1, 1993
Unresolved pulmonary embolism: the role of fibrinolysisJ O Cullis, M Chisholm, D M Ackery
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Graft vs. leukaemia reactions in chronic myeloid leukaemiaJ O Cullis, A J Barrett, J M Goldman
Vox Sanguinis|January 1, 1995
Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destructionJ O Cullis, N Win, J M Dudley, et al.
Bone Marrow Transplantation|January 1, 1991
Is graft versus leukaemia separable from graft versus host disease?Y Z Jiang, D Macdonald, J O Cullis, et al.
Leukemia|January 1, 1994
Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: studies in antigen-processing defective cell linesJ O Cullis, A J Barrett, J M Goldman, et al.
Bone Marrow Transplantation|February 1, 1993
T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemiaY Z Jiang, J O Cullis, E J Kanfer, et al.
Pageof 3